1. Home
  2. CPIX

CPIX

Cumberland Pharmaceuticals Inc.

Logo Cumberland Pharmaceuticals Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Founded: N/A Country:
United States
United States
Employees: N/A City: NASHVILLE,
Market Cap: 23.8M IPO Year: 2009
Target Price: N/A AVG Volume (30 days): 10.6K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.44 EPS Growth: N/A
52 Week Low/High: $1.43 - $2.36 Next Earning Date: 05-07-2024
Revenue: $39,552,507 Revenue Growth: -5.85%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: